Showing results (1-10 of 28) with videos related to

Sort By:
Pageof 3
Statistical Methods in Medical Research|September 4, 2008
A deterministic model for estimating the reduction in colorectal cancer incidence due to endoscopic surveillanceFay H Cafferty, Peter D Sasieni, Stephen W Duffy
Journal of Medical Screening|December 15, 2007
Surrogate endpoints for cancer screening trials: general principles and an illustration using the UK Flexible Sigmoidoscopy Screening TrialJack Cuzick, Fay H Cafferty, Robert Edwards, et al.
Women'S Health (London, England)|October 6, 2020
The role of aspirin in the prevention of ovarian, endometrial and cervical cancersNalinie Joharatnam-Hogan, Fay H Cafferty, Archie Macnair, et al.
European Journal of Cancer (Oxford, England : 1990)|February 3, 2020
Long-term outcomes with intensive induction chemotherapy (carboplatin, bleomycin, vincristine and cisplatin/bleomycin, etoposide and cisplatin) and standard bleomycin, etoposide and cisplatin in poor prognosis germ cell tumours: A randomised phase II trial (ISRCTN53643604)Fay H Cafferty, Jeff D White, Jonathan Shamash, et al.
Journal of Psychopharmacology (Oxford, England)|November 8, 2005
Chronic treatment with modafinil may not be beneficial in patients with chronic fatigue syndromeDelia C Randall, Fay H Cafferty, John M Shneerson, et al.
The Annals of Thoracic Surgery|March 28, 2006
Total arterial revascularization is safe: multicenter ten-year analysis of 71,470 coronary proceduresRoger J F Baskett, Fay H Cafferty, Sarah J Powell, et al.
Cancer Journal (Sudbury, Mass.)|September 1, 2007
Findings at follow-up endoscopies in subjects with suspected colorectal abnormalities: effects of baseline findings and time to follow-upFay H Cafferty, Jau-Min Wong, Amy Ming-Fang Yen, et al.
European Urology|July 9, 2014
A randomised phase 2 trial of intensive induction chemotherapy (CBOP/BEP) and standard BEP in poor-prognosis germ cell tumours (MRC TE23, CRUK 05/014, ISRCTN 53643604)Robert A Huddart, Rhian Gabe, Fay H Cafferty, et al.
American Society of Clinical Oncology Educational Book. American Society of Clinical Oncology. Annual Meeting|May 30, 2024
Personalizing Locoregional Therapy in Patients With Breast Cancer in 2024: Tailoring Axillary Surgery, Escalating Lymphatic Surgery, and Implementing Evidence-Based Hypofractionated RadiotherapyWalter Paul Weber, Summer E Hanson, Daniel E Wong, et al.
Breast Cancer Research and Treatment|July 16, 2008
Population estimates of survival in women with screen-detected and symptomatic breast cancer taking account of lead time and length biasGill Lawrence, Matthew Wallis, Prue Allgood, et al.
Pageof 3